Controversy Surrounding American Young People Switching to E-Cigarettes

Regulations by 2FIRSTS.ai
Feb.27.2024
Controversy Surrounding American Young People Switching to E-Cigarettes
AHA expresses concern over American youth switching to e-cigarettes, sparking debate among medical experts.

According to a report by The Libertarian Republic, the American Heart Association (AHA) has expressed concern about the trend of young people in the United States switching from tobacco cigarettes to e-cigarettes. However, medical experts argue that there is a contradiction in AHA's statement, as they believe that vaping e-cigarettes is not necessarily a form of tobacco use.

 

The AHA stated in a press release that while the decreasing trend of adolescent smoking is a gratifying victory, the success is overshadowed by the alarming trend of young Americans turning to e-cigarettes and cigars, moving away from traditional cigarettes.

 

Dr. Michael Siegel, a professor in the Department of Community Health Sciences at the School of Public Health at Boston University, noticed contradictions in the statement issued by the American Heart Association. He wrote, "The American Heart Association first expressed pleasure at the decrease in youth smoking rates, but then in the same sentence, expressed dissatisfaction with youth staying away from smoking.

 

Dr. Siegel first corrected the American Heart Association's statement that e-cigarettes are tobacco products. " 'Using e-cigarettes' is not a form of tobacco use. E-liquid does not contain any tobacco, and using e-cigarettes does not involve the heating or burning of tobacco. Therefore, youth using e-cigarettes should not be considered youth using tobacco. 'Using e-cigarettes' is definitely not a form of tobacco use," Dr. Siegel said.

 

He further pointed out: "Even when given the opportunity to clarify their conflicting statements, the American Heart Association chooses to stand by their view that the transition of teenagers from tobacco cigarettes to non-tobacco cigarettes (e-cigarettes) is concerning. Essentially, they are saying that the trend of significantly reducing smoking by keeping kids away from the most toxic consumer product is alarming, because there are teenagers occasionally vaping e-cigarettes (we know, very few kids regularly vape e-cigarettes, much less than those who smoke).

 

Dr. Siegel, who has worked in the field of tobacco control for 25 years, feels saddened by his former colleagues' dogmatic resistance to e-cigarettes.

 

I am troubled and disappointed by the recent trend from the organization I have been working with for many years, which is to urge children to stay away from smoking. What is truly disturbing is that, due to the anti-smoking campaigns, they have come to believe that smoking is no more dangerous than vaping e-cigarettes, causing teenagers to start smoking again.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
RJR Vapor Loses Tax Refund Case as Texas High Court Finds VELO Pouches Taxable
The Texas Supreme Court issued a case summary on May 8, 2026, describing its decision in Hancock v. RJR Vapor Co. LLC. The dispute centered on whether RJR Vapor’s VELO oral nicotine pouches are taxable as “tobacco products” under the Texas Tax Code. Lower courts had held that the pouches were not taxable tobacco products, but the Texas Supreme Court reversed, concluding that VELO pouches are taxable because they are made of “a tobacco substitute.”
May.09 by 2FIRSTS.ai
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Product | Geek Bar BURJ 80K Extends High-Puff Competition Into Hookah-Style DTL Use
Product | Geek Bar BURJ 80K Extends High-Puff Competition Into Hookah-Style DTL Use
2Firsts has noted that Geek Bar has added BURJ to its official product portfolio under the E-HOOKAH category. Public information shows that BURJ 80K is a hookah-style disposable vape featuring a 25ml e-liquid capacity, a 1500mAh battery, 0.4Ω dual coils and three operating modes: ECO, Regular and Pulse. According to publicly available product information, the device is rated for up to 80,000 puffs in ECO mode and uses a nicotine strength of 0.5% (5mg/ml).
Market
May.29
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
According to Bloomberg, Philip Morris International’s Zyn is facing growing competition in the U.S. nicotine pouch market as consumers shift toward moister alternatives such as British American Tobacco’s Velo Plus.
BATPMI
May.22
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Special Report|U.S.-Facing Retailer Lists RELX Creator Pro 15K: A Chinese Brand Signal Under FDA’s Lower-Priority Enforcement Window
Vapesourcing has listed RELX Creator Pro 15K as “Coming Soon” with U.S. warehouse shipping options; while the page does not show that RELX has entered the U.S. market through official channels or that the product has received FDA authorization, the listing suggests that Chinese brand-led ENDS products are becoming a new point of observation as the U.S. market reassesses regulatory risk following the FDA’s updated enforcement-priority policy.
Industry Insight
Jun.11